Collaborations & Alliances

Aptar Pharma Enters Exclusive Partnership with Stallergenes Greer

Will develop a novel digital health ecosystem for allergen immunotherapy treatment.

Author Image

By: Charlie Sternberg

Associate Editor

Aptar Pharma, a leader in drug delivery systems, services and active material science solutions, has entered an exclusive partnership with Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), for the development of a new connected drug delivery device and companion mobile app, the first of its kind, for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions.   Non-adherence to an AIT schedule and premature discontinuation of tre...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters